La maladie de Parkinson en France (serveur d'exploration) - Curation (Ncbi)

Index « Keywords » - entrée « Genetic Therapy (methods) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Genetic Therapy (legislation & jurisprudence) < Genetic Therapy (methods) < Genetic Therapy (trends)  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 13.
Ident.Authors (with country if any)Title
000204 (2001) M. Giménez Y Ribotta [France]Gene therapy strategies in neurodegenerative diseases.
000410 (2004) N A Do Thi [France] ; P. Saillour ; L. Ferrero ; J F Dedieu ; J. Mallet ; T. PaunioDelivery of GDNF by an E1,E3/E4 deleted adenoviral vector and driven by a GFAP promoter prevents dopaminergic neuron degeneration in a rat model of Parkinson's disease.
000425 (2003) Pierre-François Pradat [France] ; Jacques MalletGene transfer into the central and peripheral nervous system: applications for the treatment of neurodegenerative diseases and peripheral neuropathies.
000541 (2006) Mara Brizard [France] ; Carole Carcenac ; Alexis-Pierre Bemelmans ; Claude Feuerstein ; Jacques Mallet ; Marc SavastaFunctional reinnervation from remaining DA terminals induced by GDNF lentivirus in a rat model of early Parkinson's disease.
000575 (2006) Martine Barkats [France] ; Philippe Horellou ; Philippe Colin ; Stéphanie Millecamps ; Nicole Faucon-Biguet ; Jacques Mallet1-methyl-4-phenylpyridinium neurotoxicity is attenuated by adenoviral gene transfer of human Cu/Zn superoxide dismutase.
000668 (2007) N A Do Thi [France] ; P. Saillour ; L. Ferrero ; T. Paunio ; J. MalletDoes neuronal expression of GDNF effectively protect dopaminergic neurons in a rat model of Parkinson's disease?
000D19 (2011) Patrice P. Denèfle [France]Introduction to gene therapy: a clinical aftermath.
000D98 (????) Claire Golé [France] ; Romain Reboul ; Pascale Pisano[Gene therapy in Parkinson disease: a promising future treatment?].
001280 (2014) Maria E. Hernandez [Mexique] ; Jesus D. Rembao [Mexique] ; Daniel Hernandez-Baltazar [Mexique] ; Rosa A. Castillo-Rodriguez [Mexique] ; Victor M. Tellez-Lopez [Mexique] ; Yazmin M. Flores-Martinez [Mexique] ; Carlos E. Orozco-Barrios [Mexique] ; Hector A. Rubio [Mexique] ; Aurora Sánchez-García [Mexique] ; Jose Ayala-Davila [Mexique] ; Martha L. Arango-Rodriguez [Chili] ; Lenin Pav N [Mexique] ; Teresa Mejia-Castillo [Mexique] ; Patricia Forgez [France] ; Daniel Martinez-Fong [Mexique]Safety of the intravenous administration of neurotensin-polyplex nanoparticles in BALB/c mice.
001305 (2014) Stéphane Palfi [France] ; Jean Marc Gurruchaga [France] ; G Scott Ralph [Royaume-Uni] ; Helene Lepetit [France] ; Sonia Lavisse [France] ; Philip C. Buttery [Royaume-Uni] ; Colin Watts [Royaume-Uni] ; James Miskin [Royaume-Uni] ; Michelle Kelleher [Royaume-Uni] ; Sarah Deeley [Royaume-Uni] ; Hirokazu Iwamuro [France] ; Jean Pascal Lefaucheur [France] ; Claire Thiriez [France] ; Gilles Fenelon [France] ; Cherry Lucas [Royaume-Uni] ; Pierre Brugières [France] ; Inanna Gabriel [France] ; Kou Abhay [France] ; Xavier Drouot [France] ; Naoki Tani [France] ; Aurelie Kas [France] ; Bijan Ghaleh [France] ; Philippe Le Corvoisier [France] ; Patrice Dolphin [France] ; David P. Breen [Royaume-Uni] ; Sarah Mason [Royaume-Uni] ; Natalie Valle Guzman [Royaume-Uni] ; Nicholas D. Mazarakis [Royaume-Uni] ; Pippa A. Radcliffe [Royaume-Uni] ; Richard Harrop [Royaume-Uni] ; Susan M. Kingsman [Royaume-Uni] ; Olivier Rascol [France] ; Stuart Naylor [Royaume-Uni] ; Roger A. Barker [Royaume-Uni] ; Philippe Hantraye [France] ; Philippe Remy [France] ; Pierre Cesaro [France] ; Kyriacos A. Mitrophanous [Royaume-Uni]Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial.
001339 (2014) M. Anheim [France][Triple-gene therapy in Parkinson disease (ProSavin): toward a putaminal dopamine factory?].
001584 (2014) P. Remy [France]Biotherapies for Parkinson disease.
001956 (2016) Yves LévyGene and Cell Therapies: Inserm at the Heart of Biomedical Revolutions.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Genetic Therapy (methods)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Genetic Therapy (methods)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Genetic Therapy (methods)
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024